Medication adherence in inherited metabolic disease patients
Part of Hormones & metabolism clinical trials.
This study looks at how well patients with hereditary metabolic diseases take their daily oral medications. It aims to understand if there are challenges with sticking to the treatment plan.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a hereditary metabolic disease that requires a daily oral medication (pills or liquid).
- You are at least 7 years old.
- You or your parent/guardian can understand and speak French.
- You or your parent/guardian agree to take part in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at children who may have genetic (inherited) or metabolic (body chemistry) problems, including newborn screening and episodes of trouble. The goal is to better understand these conditions and identify children who may benefit from further care.
This trial studies eating disorders in young children with certain inherited metabolic diseases that require a special diet. It aims to understand how often these eating problems happen and what they look like.
This study looks at how people aged 65 and older understand their long-term medications (treatments taken for more than 3 months). It aims to improve communication between patients and doctors.
This study looks at your health “risk profile” in a hospital group of people with metabolic conditions like diabetes, obesity, or metabolic syndrome. It mainly focuses on measuring factors to better understand who is at higher risk of health problems over time.
This study looks at why some people take their long-term medicines as prescribed and others don't. By understanding the reasons, researchers hope to find better ways to support patients in managing their health.
This study looks at how antipsychotic medicines affect metabolism in children ages 5-17. It compares those with and without metabolic issues, and a group not taking these medicines, to understand how their bodies process energy.
Hear when a new Metabolic Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.